NovaBridge Biosciences: accounts_receivable
| Value | {"unit": "CNY", "value": 0, "concept": "us-gaap:AccountsReceivableNetCurrent"} |
|---|---|
| Period | (as of 2022-12-31) |
| Status | superseded |
| Entity | NovaBridge Biosciences |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T18:00:43.919806+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/cad0d74d-229a-4e29-9fda-3c678badf8bc
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001104659-23-053462Retrieved: 2026-08-19T18:00:43.919806+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001778016/accounts-receivable/2022-12-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/cad0d74d-229a-4e29-9fda-3c678badf8bc
History
- no predecessors — first report